Physician profile
Robert G Blake
NPI 1023036548
$928.04
in general payments reported to CMS, 2019-2025
9 companies · $134 in 2025
The $134 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $17.83 · 2020: $85.83 · 2021: $17.52 · 2022: $81.11 · 2023: $260 · 2024: $332 · 2025: $134.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $726.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $725.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Viiv Healthcare Company | $408.70 | 2022-2025 | Apretude |
| Merck Sharp & Dohme LLC | $128.27 | 2020-2025 | Vaxneuvance, Gardasil 9, Gardasil |
| Coopersurgical, INC. | $121.82 | 2020-2024 | Paragard T 380a |
| Organon LLC | $66.14 | 2021-2024 | Nexplanon |
| Bayer Healthcare Pharmaceuticals INC. | $52.69 | 2019-2025 | |
| Lupin INC. | $47.94 | 2020 | |
| Shield Therapeutics INC | $47.17 | 2025 | |
| Astellas Pharma US INC | $29.53 | 2023 | Veozah |
| Exeltis, USA INC. | $25.78 | 2024 | Slynd |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Blake listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.